Get all your news in one place.
100's of premium titles.
One app.
Start reading
AAP
AAP
Bray Boland

Dangerous replicas of weight-loss drug Ozempic banned

Replica injectable weight-loss drugs will be banned to protect Australians from severe side effects that have led to hospitalisation. 

Medications that mimic appetite suppressant diabetes drugs Ozempic and Mounjaro will be prohibited from October.

About 20,000 Australians inject the imitation medication, leading to a rise in hospitalisations from adverse effects of the unregulated products.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.